Kazuki Matsui

In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib

Yasuhiro Tsume, Susumu Takeuchi, Kazuki Matsui et al. · European Journal of Pharmaceutical Sciences · 2015 · 82 citations

Pharmaceutical Science, Vitro Dissolution Methodology, Weak Base Drug +6

Cerasome as an Infusible, Cell-Friendly, and Serum-Compatible Transfection Agent in a Viral Size

Kazuki Matsui, Shinsuke Sando, Takashi Sera et al. · Journal of the American Chemical Society · 2006 · 81 citations

IL-6-mediated Th17 differentiation through RORγt is essential for the initiation of experimental autoimmune myocarditis

Tomomi Yamashita, Tomohiko Iwakura, Kazuki Matsui et al. · Cardiovascular Research · 2011 · 80 citations

<i>In Vitro</i> Dissolution of Fluconazole and Dipyridamole in Gastrointestinal Simulator (GIS), Predicting <i>in Vivo</i> Dissolution and Drug–Drug Interaction Caused by Acid-Reducing Agents

Kazuki Matsui, Yasuhiro Tsume, Gregory E. Amidon et al. · Molecular Pharmaceutics · 2015 · 63 citations

Pharmaceutical Science, Gastrointestinal Simulator, Drug–drug Interaction +19

Discovery of a novel potent Na+/Ca2+ exchanger inhibitor: design, synthesis and structure–activity relationships of 3,4-dihydro-2(1H)-quinazolinone derivatives

Hirohiko Hasegawa, Masami Muraoka, Kazuki Matsui et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 57 citations